scutellarin has been researched along with Reperfusion Injury in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 13 (56.52) | 24.3611 |
| 2020's | 7 (30.43) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HD; Jiang, MZ; Lai, Y; Lan, H; Li, X; Yang, WQ; Zhao, YY | 1 |
| Li, D; Li, S; Li, Y | 1 |
| Hongyun, H; Liqiang, Y; Pengyue, Z; Tao, G; Yihao, D | 1 |
| Guan, Y; Guo, C; Wang, S; Wei, G; Wen, A; Weng, Y; Xi, M; Yin, Y; Zhu, Y | 1 |
| Chen, Z; Dong, L; Jiang, Q; Li, X; Wang, Y; Wu, X; Zhang, G; Zhen, Y | 1 |
| Gong, J; Li, K; Liang, XH; Lin, YZ; Lu, ZY; Peng, B | 1 |
| Lei, H; Liao, W; Liu, H; Wei, L | 1 |
| Dai, Y; Ma, R; Sun, JL; Sun, JZ; Zhang, XQ | 1 |
| Dai, J; Guan, C; Jiang, W; Li, C; Luo, C; Wang, L; Xu, Y; Yang, C; Zhang, N; Zhang, Y; Zhao, L; Zhou, B | 1 |
| Bai, N; Huo, Q; Vijayalakshmi, A; Wang, J; Zhang, X; Zhang, Y; Zhang, Z; Zhao, J | 1 |
| Deng, X; Liu, X; Liu, Y; Shi, J; Wang, C; Yan, X; Zhang, Y | 1 |
| Ding, M; Fan, L; Ge, W; Gu, S; Meng, X; Sun, X; Wang, F; Wang, Z; Xie, X; Xing, X; Zhang, W | 1 |
| Jia, L; Wu, H | 1 |
| Fan, G; Liang, W; Liu, G; Tang, G; Wang, Y; Wang, Z; Xu, W; Zhao, M | 1 |
| Chen, LM; Gao, HM; Gong, LL; Liang, RX; Liu, XQ; Ma, XJ; Wang, L; Wang, ZM; Yin, XJ | 1 |
| Elgendy, HA; Elwan, WM; Ibrahim, MAA | 1 |
| Adah, D; Chai, L; Guo, H; Hu, LM; Li, H; Liu, Y; Shi, F; Wang, S; Wang, YL | 1 |
| Duan, JA; Guo, J; Li, N; Shang, E; Shi, Q; Tang, H; Tang, Y | 1 |
| Chen, C; Chen, YJ; Hu, N; Li, QQ; Liu, YT; Qing, C; Wang, L; Yang, WM; Yu, XL; Zhang, YH; Zhou, GY | 1 |
| Chen, T; Gong, Z; Hu, J; Lan, Y; Li, Y; Liu, T; Lu, Y; Mi, L; Wang, A; Wang, Y; Yang, W; Zheng, J | 1 |
| Cheng, C; Liu, Q; Lu, J; Luo, G; Wang, Y; Yang, P; Zhao, X | 1 |
| Fu, Y; Li, NG; Qian, L; Shen, M; Shi, Q; Tang, H; Tang, Y; Zhang, L | 1 |
| Hu, XM; Zeng, FD; Zhou, MM | 1 |
23 other study(ies) available for scutellarin and Reperfusion Injury
| Article | Year |
|---|---|
Effects of breviscapine on cerebral ischemia-reperfusion injury and intestinal flora imbalance by regulating the TLR4/MyD88/NF-κB signaling pathway in rats.
Topics: Animals; Brain Ischemia; Cytochrome P-450 CYP3A; Drugs, Chinese Herbal; Erigeron; Flavonoids; Gastrointestinal Microbiome; Molecular Docking Simulation; Myeloid Differentiation Factor 88; NF-kappa B; Nimodipine; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; RNA, Ribosomal, 16S; Signal Transduction; Toll-Like Receptor 4 | 2023 |
Breviscapine Alleviates Cognitive Impairments Induced by Transient Cerebral Ischemia/Reperfusion through Its Anti-Inflammatory and Anti-Oxidant Properties in a Rat Model.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Brain Ischemia; China; Cognitive Dysfunction; Flavonoids; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury | 2020 |
Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra.
Topics: Animals; Astrocytes; Autophagy; Beclin-1; Brain; Brain Ischemia; Disease Models, Animal; Flavonoids; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neurons; Neuroprotection; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke | 2017 |
Therapeutic time window and underlying therapeutic mechanism of breviscapine injection against cerebral ischemia/reperfusion injury in rats.
Topics: Animals; Brain Ischemia; Erigeron; Flavonoids; Male; Molecular Structure; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2014 |
Vitexin protects brain against ischemia/reperfusion injury via modulating mitogen-activated protein kinase and apoptosis signaling in mice.
Topics: Animals; Apigenin; Apoptosis; bcl-2-Associated X Protein; Brain Ischemia; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Infarction, Middle Cerebral Artery; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury | 2015 |
Effect of breviscapine against hepatic ischemia reperfusion injury.
Topics: Animals; Biomarkers; Blotting, Western; Drug Administration Schedule; Drugs, Chinese Herbal; Flavonoids; Injections, Intravenous; Liver; Male; Oxidative Stress; Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Treatment Outcome | 2016 |
[Effects of Dengzhan Xixin on blood-brain barrier permeability and metabolites after cerebral ischemia-reperfusion injuries].
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Flavonoids; Male; Permeability; Rats; Rats, Wistar; Reperfusion Injury; Water | 2009 |
Amelioration of graft ischemia-reperfusion injury by breviscapine in rat small bowel transplantation.
Topics: Animals; Drugs, Chinese Herbal; Flavonoids; Intestine, Small; Male; Rats; Rats, Wistar; Reperfusion Injury; Transplantation, Homologous | 2006 |
Scutellarin protects the kidney from ischemia/reperfusion injury by targeting Nrf2.
Topics: Acute Kidney Injury; Animals; Apigenin; Apoptosis; Glucuronates; Heme Oxygenase-1; Kidney; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; RNA, Small Interfering | 2022 |
Scutellarin alleviates cerebral ischemia/reperfusion by suppressing oxidative stress and inflammatory responses via MAPK/NF-κB pathways in rats.
Topics: Animals; Anti-Inflammatory Agents; Brain Injuries; Brain Ischemia; NF-kappa B; Oxidative Stress; Rats; Reperfusion; Reperfusion Injury | 2022 |
Scutellarin Alleviates Ischemic Brain Injury in the Acute Phase by Affecting the Activity of Neurotransmitters in Neurons.
Topics: Animals; Brain Injuries; Brain Ischemia; Infarction, Middle Cerebral Artery; Molecular Docking Simulation; Neurons; Neurotransmitter Agents; Rats; Reperfusion Injury; Stroke | 2023 |
Scutellarin attenuates oxidative stress and neuroinflammation in cerebral ischemia/reperfusion injury through PI3K/Akt-mediated Nrf2 signaling pathways.
Topics: Animals; Antioxidants; Brain Ischemia; Humans; Neuroinflammatory Diseases; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Reperfusion Injury; Signal Transduction | 2023 |
Scutellarin attenuates hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and oxidative stress through regulating Keap1/Nrf2/ARE signaling.
Topics: Apigenin; Apoptosis; Carboxylic Ester Hydrolases; Cell Line; Cell Survival; Glucuronates; Heme Oxygenase-1; Hepatocytes; Humans; Hypoxia; Kelch-Like ECH-Associated Protein 1; Malondialdehyde; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction | 2019 |
PK-PD Correlation of Erigeron Breviscapus Injection in the Treatment of Cerebral Ischemia-Reperfusion Injury Model Rats.
Topics: Animals; Apigenin; Chromatography, High Pressure Liquid; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Erigeron; Glucuronates; Infarction, Middle Cerebral Artery; Injections, Intravenous; Male; Molecular Structure; Phytotherapy; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2021 |
[Protective effect and mechanism of scutellarin ethyl ester on focal cerebral ischemia induced by ligation of middle cerebral artery in rats].
Topics: Animals; Apigenin; Brain Ischemia; Glucuronates; Infarction, Middle Cerebral Artery; Male; Middle Cerebral Artery; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2017 |
Role of Scutellarin in Ameliorating Lung Injury in a Rat Model of Bilateral Hind Limb Ischemia-Reperfusion.
Topics: Animals; Apigenin; Disease Models, Animal; Glucuronates; Hindlimb; Lung Injury; Male; Rats; Rats, Wistar; Reperfusion Injury | 2019 |
Scutellarin and caffeic acid ester fraction, active components of Dengzhanxixin injection, upregulate neurotrophins synthesis and release in hypoxia/reoxygenation rat astrocytes.
Topics: Animals; Apigenin; Astrocytes; Brain; Brain Ischemia; Brain-Derived Neurotrophic Factor; Caffeic Acids; Cell Line, Tumor; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Drugs, Chinese Herbal; Glial Cell Line-Derived Neurotrophic Factor; Glucuronates; Hypoxia; Male; Mice; Nerve Growth Factor; Oncogene Protein v-akt; Rats; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Up-Regulation | 2013 |
Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats.
Topics: Amino Acids; Animals; Antioxidants; Apigenin; Brain; Brain Injuries; Brain Ischemia; CA1 Region, Hippocampal; Calcium; Calcium-Transporting ATPases; Glucuronates; Learning; Male; Memory; Neuroprotective Agents; Nimodipine; Potassium; Rats; Rats, Wistar; Reperfusion Injury; Sodium; Sodium-Potassium-Exchanging ATPase | 2014 |
Scutellarin attenuates endothelium-dependent aasodilation impairment induced by hypoxia reoxygenation, through regulating the PKG signaling pathway in rat coronary artery.
Topics: Animals; Apigenin; Cell Adhesion Molecules; Cell Hypoxia; Coronary Vessels; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Glucuronates; Microfilament Proteins; NG-Nitroarginine Methyl Ester; Phosphoproteins; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Thionucleotides; Vasodilation | 2015 |
Pharmacokinetic Comparison of Scutellarin and Paeoniflorin in Sham-Operated and Middle Cerebral Artery Occlusion Ischemia and Reperfusion Injury Rats after Intravenous Administration of Xin-Shao Formula.
Topics: Animals; Apigenin; Disease Models, Animal; Glucosides; Glucuronates; Infarction, Middle Cerebral Artery; Male; Medicine, Chinese Traditional; Monoterpenes; Plant Extracts; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke | 2016 |
PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury.
Topics: Animals; Apigenin; Disease Models, Animal; Drug Evaluation, Preclinical; Glucuronates; Infarction, Middle Cerebral Artery; Molecular Structure; Molecular Weight; Polyethylene Glycols; Prodrugs; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Solubility; Stereoisomerism; Water | 2010 |
Synthesis and protective effect of scutellarein on focal cerebral ischemia/reperfusion in rats.
Topics: Animals; Apigenin; Brain Ischemia; Glucuronates; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Rats; Reperfusion Injury | 2012 |
Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion.
Topics: Animals; Apigenin; Blood-Brain Barrier; Brain; Brain Ischemia; Erigeron; Fibroblast Growth Factor 2; Glucuronates; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vascular Endothelial Growth Factor A | 2005 |